Schedule 13G ownership disclosure

INVIVO THERAPEUTICS HOLDINGS CORP.

Security class unavailable · CUSIP: 46186M100

Event date: 2014-05-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,557,717
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-14-000059
Form type
SC 13G
Filer
INVIVO THERAPEUTICS HOLDINGS CORP.
CIK
CIK 1292519
Filed
May 14, 2014
Reporting period
May 06, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub